Biocon To Raise Rs 4,500 Crore Through QIP

Biocon Ltd is preparing to launch a Qualified Institutional Placement (QIP) worth up to ₹4,500 crore in a strategic move to reduce debt and bolster its balance sheet. The Bengaluru-based biopharmaceutical company, led by Kiran Mazumdar-Shaw, is likely to initiate the QIP as early as this week. Three major investment banks, Kotak Mahindra Capital, Goldman Sachs, and BofA Securities, are on board for advisory.

Investment Banks on Board

The fundraising exercise will be advised by a trio of major investment banks: Kotak Mahindra Capital, Goldman Sachs, and BofA Securities. All three institutions are expected to be key in structuring and executing the QIP.

Capital Strategy and Debt Reduction

The company received board approval on April 23 to raise funds through QIP, rights issues, or other permissible means in one or more tranches. In a May 14 interview, Executive Chairperson Kiran Mazumdar-Shaw stated that the goal is to complete the fundraising within three to four months. She emphasized the intent to convert venture debt into promoter equity to create a healthier balance sheet. Biocon currently has a net debt of approximately $1.2 billion, excluding structured instruments.

Strong Financial Performance in Q4 FY25

In the fourth quarter of FY25, Biocon reported robust earnings. Net profit after exceptional items surged 154 percent year-on-year to ₹344.5 crore, while revenue grew by 12.8 percent to ₹4,417 crore, surpassing expectations. EBITDA also rose by 17.7 percent YoY to ₹1,078.2 crore.

IPO or Merger Ahead for Biosimilars Arm?

Shaw also hinted at a potential merger of its biosimilars division, Biocon Biologics, with the parent company, citing current market unpredictability around IPOs. “If things suddenly change and it makes it very attractive to have an IPO, we will have an IPO. Otherwise, we will merge,” she said.

Outlook

Biocon’s QIP move marks a pivotal step in financial restructuring and future growth strategy. The shares of the company reflects this sentiment with a gradual upward trend. Opening higher at ₹358.30 compared to the previous close of ₹355.40, and trading at ₹356.75 as of 2:47 PM IST, the shares marked a 0.38% intraday gain.

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations